Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


1 Ann Surg
1 BMC Cancer
1 Br J Surg
1 Cancer Lett
1 J Clin Oncol
2 Oncol Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Surg

  1. CHOI YY, Kim H, Shin SJ, Kim HY, et al
    Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study.
    Ann Surg. 2018 May 1. doi: 10.1097/SLA.0000000000002803.
    PubMed     Text format     Abstract available

    BMC Cancer

  2. WANG G, Zhao J, Song Y, Zhang W, et al
    Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer.
    BMC Cancer. 2018;18:547.
    PubMed     Text format     Abstract available

    Br J Surg

  3. KANDA M, Shimizu D, Tanaka H, Tanaka C, et al
    Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer.
    Br J Surg. 2018 May 9. doi: 10.1002/bjs.10876.
    PubMed     Text format     Abstract available

    Cancer Lett

  4. MIN A, Eun Kim J, Kim YJ, Min Lim J, et al
    Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells.
    Cancer Lett. 2018 May 2. pii: S0304-3835(18)30310.
    PubMed     Text format     Abstract available

    J Clin Oncol

  5. ISHIGAMI H, Fujiwara Y, Fukushima R, Nashimoto A, et al
    Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial.
    J Clin Oncol. 2018 May 10:JCO2018778613. doi: 10.1200/JCO.2018.77.8613.
    PubMed     Text format     Abstract available

    Oncol Rep

  6. KUMATA Y, Iinuma H, Suzuki Y, Tsukahara D, et al
    Exosomeencapsulated microRNA23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage.
    Oncol Rep. 2018 May 8. doi: 10.3892/or.2018.6418.
    PubMed     Text format     Abstract available

  7. XU G, Meng L, Yuan D, Li K, et al
    MEG3/miR21 axis affects cell mobility by suppressing epithelialmesenchymal transition in gastric cancer.
    Oncol Rep. 2018 May 8. doi: 10.3892/or.2018.6424.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.